Kim Bong Kyun, Ryu Jai Min, Oh Se Jeong, Han Jaihong, Choi Jung Eun, Jeong Joon, Suh Young Jin, Lee Jina, Sun Woo Young
Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea.
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ann Surg Treat Res. 2021 Sep;101(3):131-139. doi: 10.4174/astr.2021.101.3.131. Epub 2021 Aug 31.
The Breast Imaging Reporting and Data System (BI-RADS) is a systematic and standardized scheme of the radiological findings of breast. However, there were different BI-RADS categories between breast cancers as the clinical characteristics in previous studies. We analyzed the association of BI-RADS categories with the clinicopathological characteristics and prognosis of breast cancer.
A total of 44,184 patients with invasive breast cancers assigned to BI-RADS category 3, 4, or 5 in preoperative mammography or ultrasonography were analyzed retrospectively using large-scale data from the Korean Breast Cancer Society registration system. The difference in the clinicopathological factors and prognoses according to the BI-RADS categories (BI-RADS 3-4 and BI-RADS 5) were compared between the mammography and ultrasonography groups. Comparisons of the clinicopathological factors in both groups were made using logistic regression analysis, while the prognoses were based on the breast cancer-specific survival using the Kaplan-Meier method and Cox proportional hazards model.
The factors associated with BI-RADS were T stage, N stage, palpability, histology grade, and lymphovascular invasion in the mammography group; and N stage, palpability, histology grade, and lymphovascular invasion in the ultrasonography group. In the survival analysis, there were significant differences in the breast cancer-specific survival of the BI-RADS category groups in both of the mammography (hazard ratio [HR], 3.366; P < 0.001) and ultrasonography (HR, 2.877; P < 0.001) groups.
In this study, the BI-RADS categories of preoperative mammography and ultrasonography of patients with invasive breast cancer were associated with prognosis and could be an important factor in making treatment decisions.
乳腺影像报告和数据系统(BI-RADS)是一种系统且标准化的乳腺放射学检查结果分类方案。然而,既往研究显示,不同乳腺癌的临床特征对应不同的BI-RADS分类。我们分析了BI-RADS分类与乳腺癌临床病理特征及预后之间的关联。
利用韩国乳腺癌协会登记系统的大规模数据,对术前乳腺钼靶或超声检查中被归类为BI-RADS 3、4或5类的44184例浸润性乳腺癌患者进行回顾性分析。比较乳腺钼靶组和超声检查组中,根据BI-RADS分类(BI-RADS 3-4类和BI-RADS 5类)划分的临床病理因素及预后差异。两组临床病理因素的比较采用逻辑回归分析,而预后则基于使用Kaplan-Meier法和Cox比例风险模型得出的乳腺癌特异性生存率。
在乳腺钼靶组中,与BI-RADS相关的因素有T分期、N分期、可触及性、组织学分级和淋巴管浸润;在超声检查组中,与BI-RADS相关的因素有N分期、可触及性、组织学分级和淋巴管浸润。在生存分析中,乳腺钼靶组(风险比[HR],3.366;P<0.001)和超声检查组(HR,2.877;P<0.001)中,不同BI-RADS分类组的乳腺癌特异性生存率均存在显著差异。
在本研究中,浸润性乳腺癌患者术前乳腺钼靶和超声检查的BI-RADS分类与预后相关,且可能是制定治疗决策的重要因素。